Catamaran (CTRX) is set to soar this morning because it signed a new ten-year deal with Cigna. Last week I wrote in my CTRX 2013 Q2 Research Report: The Cigna deal is the cloud that hangs over this stock. If the two sides agree to continue doing business, CTRX could soar. For more read the entire research report here.
Now that a deal is done, CTRX is already up more than 10% in the pre-market. I feel this stock still has solid upside and will insert it into the Aggressive Growth Portfolio this morning. My 2013 Fair Value is $65. It will replace Francesca’s (FRAN) which isn’t very timely right now because its same store sales growth slowed last quarter.
